PROSTATE CANCER RESEARCH

ACHIEVEMENTS THROUGH THE ESTABLISHMENT OF THE PCI

INDIVIDUAL SPECIAL INTERESTS OF PCI PERSONNEL


Dr Paul de Souza: the role of clinical trial research in the development and discovery of more effective anti-cancer drugs to combat prostate cancer.


Dr Terry Diamond: endocrine assessment of men for osteoporosis following drug treatment for prostate cancer.


Dr Bill Lynch: a new treatment for local prostate cancer: cryotherapy (freezing of the prostate gland).


Dr Paul Cozzi: a new surgical technique for prostate cancer reduces the risk of side effects.


Dr Joe Bucci: I-125 seed brachytherapy and HDR brachytherapy for early stage prostate cancer.


Dr Joe Bucci: high dose-rate brachytherapy for prostate cancer.


Kim Small/Professor Kearsley: installation of multileaf collimators to improve efficacy of external beam radiotherapy for prostate cancer.


Dr Raymond Clarke: It’s all in the genes - discovering the genetic basis for prostate cancer in families.


Professor Barry Allen: a novel new approach to improving prostate cancer treatment - targeted alpha therapy.


Professor Anatoly Rozenfeld: real time physics dosimetry improves the accuracy of brachytherapy for prostate cancer patients.


Jacqueline Lim and social workers: exploring the role of support groups for men with prostate cancer.